KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to 0.35%.

  • Eli Lilly's Return on Invested Capital rose 400.0% to 0.35% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.35%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.42% for FY2025, which is 500.0% up from last year.
  • Eli Lilly's Return on Invested Capital amounted to 0.35% in Q4 2025, which was up 400.0% from 0.35% recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Return on Invested Capital ranged from a high of 0.35% in Q3 2025 and a low of 0.23% during Q2 2023
  • Its 5-year average for Return on Invested Capital is 0.29%, with a median of 0.28% in 2024.
  • Per our database at Business Quant, Eli Lilly's Return on Invested Capital skyrocketed by 900bps in 2022 and then plummeted by -1000bps in 2023.
  • Over the past 5 years, Eli Lilly's Return on Invested Capital (Quarter) stood at 0.25% in 2021, then increased by 16bps to 0.3% in 2022, then dropped by -7bps to 0.27% in 2023, then rose by 12bps to 0.31% in 2024, then increased by 12bps to 0.35% in 2025.
  • Its last three reported values are 0.35% in Q4 2025, 0.35% for Q3 2025, and 0.34% during Q2 2025.